首页 | 本学科首页   官方微博 | 高级检索  
     


Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions
Authors:Dejmek Annika  Naucler Pontus  Smedjeback Anita  Kato Harubumi  Maeda Masahiro  Yashima Koichi  Maeda Junichi  Hirano Takashi
Affiliation:1. Department of Laboratory Medicine, Malm?, Lund University, Sweden;2. Department of Clinical Cytology and Pathology, Malm? University Hospital, Sweden;3. 1st Department of Surgery, Tokyo Medical University, Nishishinjuku, Shinjuku‐ku, Tokyo 160‐0023, Japan;4. IBL, 1091 Naka, Fujioka City, Gunma, 375‐005, Japan
Abstract:The purpose of this study was to test napsin A as a diagnostic marker of metastatic lung adenocarcinoma in pleural effusions, and to compare its performance with TTF-1. Napsin A and TTF-1 reactivities were determined immunohistochemically on formalin-fixed paraffin embedded cell blocks from 50 pleural effusion (5 mesotheliomas, 10 mesothelial proliferations, 12 pulmonary, and 23 nonpulmonary metastases). The results were evaluated separately, and correlated to the final diagnoses. Concordant results were obtained in 48/50 cases. TTF-1 and Napsin A were positive in 8/12 and 10/12 pulmonary adenocarcinomas, respectively. Both markers were negative in 42 cases, including two lung carcinomas. Napsin reactivity was found in more than 75% of the tumor cells in 9/10 positive cases, whereas TTF-1 reactivity was seen in more than 75% of the tumor cells in 2/8 positive cases only (P < 0.05). This makes napsin A an alternative to TTF-1 in cytological diagnosis of effusions in which tumor cells may be scanty.
Keywords:Napsin A  TTF‐1  lung  adenocarcinoma  effusion  immunocytochemistry
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号